Andreessen Marc L — SEC Form 4 filings
SEC reporting owner CIK 1160077. 34 Form 4 filings on record with FilingPulse; latest filed 2026-09-10.
Transaction summary — filings shown
Covers all 34 filings on record, filed 2024-03-28 to 2026-09-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 16 legs across 7 filings — 4,932,846 shares, $75,653,960 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 72 legs across 12 filings — 9,483,019 shares, $177,104,451 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 120.
- Largest priced transaction: purchase of 1,100,000 shares @ $18.00 ($19,800,000) in Braveheart Bio, Inc., filed 2026-08-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Samsara Inc. (IOT) | Director | 9 | — | 54 legs · 4,462,177 sh · $160,774,229 | 70 |
| Navan, Inc. (NAVN) | 10% owner | 5 | 12 legs · 2,772,241 sh · $42,853,973 | — | 16 |
| Braveheart Bio, Inc. (BRVE) | 10% owner | 1 | 1 leg · 1,100,000 sh · $19,800,000 | — | 2 |
| Nautilus Biotechnology, Inc. (NAUT) | 10% owner | 1 | — | 2 legs · 5,000,000 sh · $11,750,000 | — |
| Camp4 Therapeutics Corp (CAMP) | 10% owner | 1 | 2 legs · 727,272 sh · $7,999,992 | — | 3 |
| Scribe Therapeutics, Inc. (SCTX) | 10% owner | 1 | 1 leg · 333,333 sh · $4,999,995 | — | 4 |
| Coinbase Global, Inc. (COIN) | Director | 6 | — | 12 legs · 20,416 sh · $4,329,315 | 7 |
| Meta Platforms, Inc. (META) | Director | 8 | — | 4 legs · 426 sh · $250,907 | 10 |
| Starco Brands, Inc. (STCB) | 10% owner | 2 | — | — | 8 |
Form 4 filings — Andreessen Marc L
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-10 | 4 | Coinbase Global, Inc. (COIN) | Sale (S): 13,676 @ $181.14 | EDGAR |
| 2026-08-11 | 4 | Braveheart Bio, Inc. (BRVE) jointly with AH Bio Fund IV, L.P., AH Equity Partners Bio IV, L.L.C., HOROWITZ BENJAMIN A | Conversion (C): 9,132,420 · Purchase (P): 1,100,000 @ $18 · Conversion (C): 40,000,000 (derivative) @ $0 | EDGAR |
| 2026-08-06 | 4 | Meta Platforms, Inc. (META) | Sale (S): 250 @ $588.16 · Sale (S): 87 @ $589.24 · Sale (S): 44 @ $590.39 · Sale (S): 45 @ $591.69 | EDGAR |
| 2026-07-29 | 4 | Scribe Therapeutics, Inc. (SCTX) jointly with AH Bio Fund II, L.P., AH Equity Partners Bio II, L.L.C., AH Bio Fund III, L.P., AH Equity Partners Bio III, L.L.C., HOROWITZ BENJAMIN A | Conversion (C): 2,051,742 · Conversion (C): 697,650 · Purchase (P): 333,333 @ $15 · Conversion (C): 12,150,003 (derivative) @ $0 · Conversion (C): 4,131,344 (derivative) @ $0 | EDGAR |
| 2026-07-24 | 4 | Samsara Inc. (IOT) | Grant/award (A): 7,801 @ $0 | EDGAR |
| 2026-06-18 | 4 | Coinbase Global, Inc. (COIN) | Option exercise (M): 1,150 @ $0 · Grant/award (A): 2,303 (derivative) @ $0 · Option exercise (M): 1,150 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Meta Platforms, Inc. (META) | Grant/award (A): 490 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Samsara Inc. (IOT) | Sale (S): 168,806 @ $32.83 · Sale (S): 331,194 @ $34.11 · Sale (S): 468,751 @ $32.18 · Sale (S): 144,909 @ $32.56 | EDGAR |
| 2026-06-10 | 4 | Samsara Inc. (IOT) | Sale (S): 531,914 @ $34.05 · Sale (S): 35,711 @ $34.73 · Sale (S): 202 @ $35.50 · Sale (S): 210,126 @ $33.37 · Sale (S): 190,605 @ $34.16 · Sale (S): 174,269 @ $34.99 | EDGAR |
| 2026-06-04 | 4 | Nautilus Biotechnology, Inc. (NAUT) jointly with AH Equity Partners Bio II, L.L.C., Andreessen Horowitz LSV Fund II, L.P., AH Bio Fund II, L.P., AH Equity Partners LSV II, L.L.C., HOROWITZ BENJAMIN A | Sale (S): 4,615,974 @ $2.35 · Sale (S): 384,026 @ $2.35 | EDGAR |
| 2026-05-19 | 4 | Meta Platforms, Inc. (META) | Option exercise (M): 480 @ $0 · Option exercise (M): 480 (derivative) @ $0 | EDGAR |
| 2026-01-09 | 4 | Navan, Inc. (NAVN) jointly with Andreessen Horowitz LSV Fund I, L.P., Andreessen Horowitz LSV Fund I-B, L.P., Andreessen Horowitz LSV Fund I-Q, L.P., AH Equity Partners LSV I, L.L.C., Andreessen Horowitz LSV Fund II, L.P., Andreessen Horowitz LSV Fund II-B, L.P., Andreessen Horowitz LSV Fund II-Q, L.P., AH Equity Partners LSV II, L.L.C. | Purchase (P): 46,337 @ $18.11 | EDGAR |
| 2026-01-06 | 4 | Navan, Inc. (NAVN) jointly with Andreessen Horowitz LSV Fund I, L.P., Andreessen Horowitz LSV Fund I-B, L.P., Andreessen Horowitz LSV Fund I-Q, L.P., AH Equity Partners LSV I, L.L.C., Andreessen Horowitz LSV Fund II, L.P., Andreessen Horowitz LSV Fund II-B, L.P., Andreessen Horowitz LSV Fund II-Q, L.P., AH Equity Partners LSV II, L.L.C. | Purchase (P): 466,058 @ $16.27 · Purchase (P): 202,729 @ $15.77 · Purchase (P): 308,188 @ $16.74 | EDGAR |
| 2025-12-29 | 4 | Navan, Inc. (NAVN) jointly with Andreessen Horowitz LSV Fund I, L.P., Andreessen Horowitz LSV Fund I-B, L.P., Andreessen Horowitz LSV Fund I-Q, L.P., AH Equity Partners LSV I, L.L.C., Andreessen Horowitz LSV Fund II, L.P., Andreessen Horowitz LSV Fund II-B, L.P., Andreessen Horowitz LSV Fund II-Q, L.P., AH Equity Partners LSV II, L.L.C. | Purchase (P): 334,112 @ $15.90 · Purchase (P): 225,484 @ $15.84 · Purchase (P): 167,519 @ $15.83 · Purchase (P): 229,917 @ $15.57 · Purchase (P): 99,502 @ $16.16 | EDGAR |
| 2025-12-19 | 4 | Navan, Inc. (NAVN) jointly with Andreessen Horowitz LSV Fund I, L.P., Andreessen Horowitz LSV Fund I-B, L.P., Andreessen Horowitz LSV Fund I-Q, L.P., AH Equity Partners LSV I, L.L.C., Andreessen Horowitz LSV Fund II, L.P., Andreessen Horowitz LSV Fund II-B, L.P., Andreessen Horowitz LSV Fund II-Q, L.P., AH Equity Partners LSV II, L.L.C. | Purchase (P): 347,600 @ $12.65 · Purchase (P): 103,960 @ $13.61 · Purchase (P): 240,835 @ $14.70 | EDGAR |
| 2025-11-04 | 4 | Navan, Inc. (NAVN) jointly with Andreessen Horowitz LSV Fund I, L.P., Andreessen Horowitz LSV Fund I-B, L.P., Andreessen Horowitz LSV Fund I-Q, L.P., AH Equity Partners LSV I, L.L.C., Andreessen Horowitz LSV Fund II, L.P., Andreessen Horowitz LSV Fund II-B, L.P., Andreessen Horowitz LSV Fund II-Q, L.P., AH Equity Partners LSV II, L.L.C. | Conversion (C): 6,757,090 · Conversion (C): 4,305,906 · Conversion (C): 607,161 · Conversion (C): 2,081,772 · Conversion (C): 17,001 · Conversion (C): 10,408,860 · +10 more | EDGAR |
| 2025-09-10 | 4 | Samsara Inc. (IOT) | Conversion (C): 1,758,907 @ $0 · Conversion (C): 10,949,014 @ $0 · Conversion (C): 994,899 @ $0 · Conversion (C): 2,573,745 @ $0 · Other (J): 1,255,907 @ $0 · Other (J): 10,949,014 @ $0 · +17 more | EDGAR |
| 2025-08-05 | 4 | Meta Platforms, Inc. (META) | Grant/award (A): 212,531 | EDGAR |
| 2025-06-23 | 4 | Coinbase Global, Inc. (COIN) | Grant/award (A): 1,150 (derivative) @ $0 | EDGAR |
| 2025-06-18 | 4 | Meta Platforms, Inc. (META) | Grant/award (A): 480 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | Coinbase Global, Inc. (COIN) | Option exercise (M): 1,390 @ $0 · Option exercise (M): 1,390 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | Samsara Inc. (IOT) | Conversion (C): 4,803,998 @ $0 · Conversion (C): 21,898,032 @ $0 · Conversion (C): 1,989,800 @ $0 · Conversion (C): 2,639,238 @ $0 · Other (J): 4,803,998 @ $0 · Other (J): 21,898,032 @ $0 · +25 more | EDGAR |
| 2025-05-22 | 4 | Starco Brands, Inc. (STCB) jointly with Andreessen Horowitz Fund IV, L.P., AH Equity Partners IV, L.L.C., AH Parallel Fund IV, L.P., AH Equity Partners IV (Parallel), L.L.C., Andreessen Horowitz Fund III, L.P., AH Equity Partners III, L.L.C., a16z Seed-III, LLC, HOROWITZ BENJAMIN A | Other (J): 38,592,602 · Other (J): 7,433,138 · Other (J): 1,960,638 · Other (J): 100,607 | EDGAR |
| 2025-05-19 | 4 | Meta Platforms, Inc. (META) | Option exercise (M): 642 @ $0 · Option exercise (M): 642 (derivative) @ $0 | EDGAR |
| 2025-03-12 | 4 | Samsara Inc. (IOT) | Conversion (C): 219,698 @ $0 · Conversion (C): 73,233 @ $0 · Sale (S): 169,818 @ $34.06 · Sale (S): 56,606 @ $34.06 · Sale (S): 49,880 @ $34.62 · Sale (S): 16,627 @ $34.62 · +2 more | EDGAR |
| 2024-12-11 | 4 | Samsara Inc. (IOT) | Conversion (C): 2,401,999 @ $0 · Conversion (C): 10,949,016 @ $0 · Conversion (C): 994,901 @ $0 · Other (J): 2,401,999 @ $0 · Other (J): 10,949,016 @ $0 · Other (J): 994,901 @ $0 · +15 more | EDGAR |
| 2024-12-02 | 4 | Starco Brands, Inc. (STCB) jointly with Andreessen Horowitz Fund IV, L.P., AH Equity Partners IV, L.L.C., AH Parallel Fund IV, L.P., AH Equity Partners IV (Parallel), L.L.C., Andreessen Horowitz Fund III, L.P., AH Equity Partners III, L.L.C., a16z Seed-III, LLC, HOROWITZ BENJAMIN A | Other (J): 31,411,937 · Other (J): 6,502,936 · Other (J): 4,066,364 · Other (J): 88,016 | EDGAR |
| 2024-10-17 | 4 | Camp4 Therapeutics Corp (CAMP) jointly with AH Equity Partners Bio I, L.L.C., AH Bio Fund I, L.P., AH Equity Partners Bio IV, L.L.C., AH Bio Fund IV, L.P., HOROWITZ BENJAMIN A | Conversion (C): 1,398,067 · Purchase (P): 181,818 @ $11 · Purchase (P): 545,454 @ $11 · Conversion (C): 15,001,312 (derivative) · Conversion (C): 679,163 (derivative) | EDGAR |
| 2024-09-12 | 4 | Samsara Inc. (IOT) | Conversion (C): 2,401,999 @ $0 · Conversion (C): 10,949,016 @ $0 · Conversion (C): 994,901 @ $0 · Other (J): 2,401,999 @ $0 · Other (J): 10,949,016 @ $0 · Other (J): 994,901 @ $0 · +20 more | EDGAR |
| 2024-06-20 | 4 | Meta Platforms, Inc. (META) | Grant/award (A): 642 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Coinbase Global, Inc. (COIN) | Grant/award (A): 1,390 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Samsara Inc. (IOT) | Conversion (C): 277,484 @ $0 · Sale (S): 265,276 @ $28.84 · Sale (S): 12,208 @ $29.72 · Conversion (C): 277,484 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Meta Platforms, Inc. (META) | Option exercise (M): 1,233 @ $0 · Option exercise (M): 1,233 (derivative) @ $0 | EDGAR |
| 2024-03-28 | 4 | Coinbase Global, Inc. (COIN) | Sale (S): 587 @ $267.08 · Sale (S): 57 @ $268.90 · Sale (S): 250 @ $270.65 · Sale (S): 199 @ $271.99 · Sale (S): 557 @ $272.82 · Sale (S): 926 @ $274.32 · +5 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1160077 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →